Fate Therapeutics Inc. has experienced a dramatic decline in its stock price and financial stability, highlighting the challenges and risks of the biotech sector, despite its promising work in stem cell therapies.

Fate Therapeutics, a biotech company specializing in regenerative medicine, navigates challenges and opportunities in the industry, with strategic initiatives and innovative therapies positioning it for potential growth.